Keyphrases
Carvedilol
100%
Inhaled Therapy
100%
Beta-blocker Therapy
100%
Cardiopulmonary Interactions
100%
Bisoprolol
83%
ICS-LABA
50%
Forced Expiratory Volume in 1 Second (FEV1)
33%
Pulmonary Function
33%
Cardiovascular Disease
16%
Beta-blockers
16%
Moderate to Severe
16%
Patient-completed
16%
Inhaled Corticosteroids
16%
Tolerability
16%
Forced Vital Capacity
16%
Long-acting beta-agonists
16%
Tiotropium
16%
Resting Heart Rate
16%
Ex-smokers
16%
Long-acting muscarinic Antagonist
16%
Formoterol
16%
Severe COPD
16%
Lung Compliance
16%
Exercise Heart Rate
16%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Carvedilol
100%
Beta Adrenergic Receptor Blocking Agent
100%
Bisoprolol
83%
Forced Expiratory Volume
33%
Lung Function
33%
Cardiovascular Disease
16%
Beta Adrenergic Receptor Stimulating Agent
16%
Forced Vital Capacity
16%
Muscarinic Antagonist
16%
Formoterol
16%
Lung Compliance
16%
Pharmacology, Toxicology and Pharmaceutical Science
Carvedilol
100%
Chronic Obstructive Lung Disease
100%
Beta Adrenergic Receptor Blocking Agent
100%
Bisoprolol
83%
Tolerability
16%
Beta Adrenergic Receptor Stimulating Agent
16%
Muscarinic Receptor Blocking Agent
16%
Formoterol
16%
Cardiovascular Disease
16%